These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 31081083

  • 21. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B, Tian X, Sun J, Meng X.
    Int J Mol Sci; 2013 Dec 02; 14(12):23559-80. PubMed ID: 24317431
    [Abstract] [Full Text] [Related]

  • 22. Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
    Sheng SL, Wang Q, Huang G, Yu B, Qin WX.
    J Clin Lab Anal; 2009 Dec 02; 23(3):179-85. PubMed ID: 19455631
    [Abstract] [Full Text] [Related]

  • 23. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhou Y, Yin X, Ying J, Zhang B.
    BMC Cancer; 2012 Jan 16; 12():17. PubMed ID: 22244200
    [Abstract] [Full Text] [Related]

  • 24. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Jan 16; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 25. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):948-51. PubMed ID: 18756964
    [Abstract] [Full Text] [Related]

  • 26. [Diagnostic value and clinical significance of the Golgi protein-73 in hepatocellular carcinoma].
    Shi QF, Pan XD, Zhang WG, Shao WF.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec 08; 26(6):480-2. PubMed ID: 23627036
    [Abstract] [Full Text] [Related]

  • 27. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
    Bao YX, Yang Y, Zhao HR, Mao R, Xiao L, Zhang YF, Aisiker T, Wen H.
    Zhonghua Zhong Liu Za Zhi; 2013 Jul 08; 35(7):505-8. PubMed ID: 24257301
    [Abstract] [Full Text] [Related]

  • 28. [Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology].
    Wu Y, Wang YP, Ma J, Zhang YH, Sun HQ, Sun JP, Wang ZK, Xu J, Dai YC, Li N.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):351-356. PubMed ID: 31137168
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.
    J Gastroenterol Hepatol; 2010 Jan 23; 25(1):129-37. PubMed ID: 19793164
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma.
    Shaker MK, Attia FM, Hassan AA, Shedid MM, Aboelmagd MA, Faisal AS.
    Clin Lab; 2020 Aug 01; 66(8):. PubMed ID: 32776730
    [Abstract] [Full Text] [Related]

  • 31. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
    Hu JS, Wu DW, Liang S, Miao XY.
    Med Oncol; 2010 Jun 01; 27(2):339-45. PubMed ID: 19399652
    [Abstract] [Full Text] [Related]

  • 32. Golgi protein 73(GP73), a useful serum marker in liver diseases.
    Liu X, Wan X, Li Z, Lin C, Zhan Y, Lu X.
    Clin Chem Lab Med; 2011 Aug 01; 49(8):1311-1316. PubMed ID: 21663469
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA, Mahmoud EH, Osman EA, Mahmoud SH, Shousha HI.
    Tumour Biol; 2014 Nov 01; 35(11):11559-64. PubMed ID: 25129443
    [Abstract] [Full Text] [Related]

  • 34. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
    Zhang Y, Xi Y, Fang J, Luo S, Wilson JJ, Huang RP.
    J Immunoassay Immunochem; 2016 Nov 01; 37(4):390-406. PubMed ID: 27088654
    [Abstract] [Full Text] [Related]

  • 35. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug 01; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 36. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H, Fan X, Wang X, Zeng L, Zhang K, Zhang X, Li N, Han Q, Lv Y, Liu Z.
    Sci Rep; 2020 Nov 20; 10(1):20276. PubMed ID: 33219288
    [Abstract] [Full Text] [Related]

  • 37. The diagnostic value of golgi protien-73 and DICKKOPF-1 in hepatocellular carcinoma.
    ElZefzafy WM, Hussien M, Mohmmed ZAZ, Abd Elbaky NM.
    J Immunoassay Immunochem; 2021 Mar 04; 42(2):174-187. PubMed ID: 33284721
    [Abstract] [Full Text] [Related]

  • 38. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
    Tian L, Wang Y, Xu D, Gui J, Jia X, Tong H, Wen X, Dong Z, Tian Y.
    Int J Cancer; 2011 Oct 15; 129(8):1923-31. PubMed ID: 21140449
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
    Li J, Tao H, Zhang E, Huang Z.
    Cancer Med; 2021 Jul 15; 10(14):4844-4854. PubMed ID: 34145988
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D, Luo Y, Chen L, Chen L, Zuo D, Li Y, Zhang X, Wu J, Xi Q, Li G, Qi L, Yue X, Zhang X, Sun Z, Zhang N, Song T, Lu W, Guo H.
    Cancer Biol Med; 2021 Feb 15; 18(1):256-270. PubMed ID: 33628599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.